November 23, 2022

Aurobindo Pharmaceutical USFDA Warning Letter- 2022

FDA Warning Letter

Aurobindo Pharmaceutical Limited MARCS-CMS 618091 — JANUARY 12, 2022 January 12, 2022 WARNING LETTER Delivery Method:VIA UPSProduct:Drugs  Recipient: Mr. Narayanan GovindarajanAurobindo Pharmaceutical Limited Floor No.’s 22, 23 & 24 Galaxy Plot No-1, Survey No: 83/1, Hyderabad Knowledge City Raidurg Panmaktha, Ranga Reddy District Hyderabad500081 Telangana IndiaIssuing Office:Center for Drug Evaluation and Research | CDER United States Warning Letter 320-22-10 January […]

Aurobindo Pharmaceutical USFDA Warning Letter- 2022 Read More »

Warning Letter of Lupin Limited 2022

FDA Warning Letter

Lupin Limited MARCS-CMS 633703 — SEPTEMBER 27, 2022 September 27, 2022 WARNING LETTER Delivery Method:Via EmailProduct:Drugs  Recipient: Site Head and Senior General Manager ManufacturingLupin Limited T-142, MIDC Tarapur via Boisar Palghar 401506Maharashtra IndiaIssuing Office:Center for Drug Evaluation and Research | CDER United States Warning Letter 320-22-25 September 27, 2022 Dear Mr. Patel: The U.S. Food and Drug Administration (FDA)

Warning Letter of Lupin Limited 2022 Read More »